Related Experiment Video
Updated: May 14, 2026
10:25
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Glucose abnormalities in hepatitis C virus infection.
Jee-Fu Huang1, Ming-Lung Yu, Chia-Yen Dai
1Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
The Kaohsiung Journal of Medical Sciences
|January 26, 2013
Summary
Hepatitis C virus (HCV) infection is linked to type 2 diabetes mellitus (T2DM), causing insulin resistance and glucose abnormalities. Understanding this link is crucial for managing both conditions and improving treatment outcomes.
Area of Science:
- Hepatology
- Endocrinology
- Virology
Background:
- Hepatitis C virus (HCV) infection is a major cause of liver disease and is linked to extrahepatic metabolic disorders.
- Type 2 diabetes mellitus (T2DM) is a significant extrahepatic manifestation of HCV infection, impacting disease progression and treatment.
- HCV is considered diabetogenic, suggesting a direct role in causing insulin resistance and glucose abnormalities.
Purpose of the Study:
- To review epidemiological and pathophysiological studies on the link between chronic HCV infection (CHC) and T2DM.
- To describe glucose abnormalities in patients with CHC and T2DM.
- To discuss the interplay between insulin resistance, CHC, and treatment efficacy, including pancreatic beta-cell function.
Main Methods:
- Review of epidemiological studies.
- Analysis of pathophysiological mechanisms.
- Synthesis of clinical findings on glucose metabolism in CHC patients.
Main Results:
- CHC is associated with increased risk of T2DM and distinct glucose abnormalities.
- HCV infection contributes to insulin resistance through mechanisms potentially differing from non-HCV related liver diseases.
- Treatment of CHC may impact insulin resistance and glucose control.
Conclusions:
- The relationship between CHC and T2DM is complex, involving shared pathophysiological pathways.
- Further research is needed to fully elucidate the mechanisms linking HCV and T2DM.
- Understanding this interaction is vital for optimizing patient management and therapeutic strategies.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...